SEC Filing Summary: Landec Corporation (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by Landec Corporation on July 31, 2012. The filing serves to announce the consolidated financial results for the fourth quarter and the fiscal year ended May 27, 2012. The detailed results are contained in a press release attached as Exhibit 99.1.
Note: The request metadata references "LIFECORE BIOMEDICAL, INC.", but the filing text explicitly identifies the registrant as "LANDEC CORPORATION". This summary reflects the entity named in the source document.
Key Financial Metrics
The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the attached press release (Exhibit 99.1), which is incorporated by reference but not included in the provided text.
Material Changes
The filing does not contain specific data regarding material changes versus prior periods. It solely acts as a notification that the results for the period ended May 27, 2012, have been issued.
Guidance, Outlook, and Risks
The text does not contain management commentary, forward-looking guidance, risk factors, or details on contingencies. The document explicitly states that the information, including the press release, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Verify the specific financial figures (revenue, net income, EPS) by reviewing the attached Exhibit 99.1 (Press Release dated July 31, 2012).
- Confirm the fiscal year-end date of May 27, 2012 when comparing to other reporting periods.
- Review the full press release for any management commentary or outlook not present in this 8-K summary.
- Note that the registrant is Landec Corporation, not Lifecore Biomedical, Inc.